![]() |
市场调查报告书
商品编码
1713233
欧洲再生牙科市场规模及预测 2021 - 2031、区域份额、趋势及成长机会分析报告涵盖范围:按产品类型、技术、应用、年龄层、最终用户和地区Europe Regenerative Dentistry Market Size and Forecast 2021 - 2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Application, Age Group, End User, and Region |
2024 年欧洲再生牙科市场价值为 8.365 亿美元,预计到 2031 年将达到 12.696 亿美元;预计 2025 年至 2031 年期间的复合年增长率为 6.3%。本报告中提供的欧洲再生牙科市场预测可以帮助该市场的利害关係人规划他们的成长策略。老龄人口中牙齿疾病的盛行率不断上升以及对美容牙科的需求不断增加是推动欧洲再生牙科市场成长的关键因素。
组织再生应用的增加
干细胞疗法改变了牙科专业人员处理牙齿和组织再生的方式,特别是对于牙齿严重损伤、牙齿脱落或牙周疾病的患者。以下是一些可能带来市场新趋势的方法:
牙齿再生和牙髓治疗:
牙髓治疗,尤其是活髓治疗(VPT),是修復牙科的重要组成部分,旨在保持受影响牙齿的活力。在欧洲,牙髓治疗技术的教学和应用各不相同:根据 PubMed 的一项欧洲牙科学校调查显示,92.9% 的学校教授使用硫酸铁对乳磨牙进行活髓切断术,这表明在教育环境中对这种材料的偏好。成熟恆牙的 VPT 成功率非常高。根据 Springer Nature Limited 2025 的回顾性研究报告,在 12-24 个月的追踪期内,使用 iRoot BP Plus 进行牙髓切断术的成功率为 99%,凸显了现代材料在牙髓治疗中的有效性。研究人员正在探索干细胞疗法来再生受损或流失的牙髓,这对于维持牙齿活力至关重要。在义大利,米兰大学等机构正在积极研究牙髓干细胞再生牙髓组织甚至重新长出功能性牙齿的潜力。这项创新可以取代根管治疗或拔牙等传统方法,为患者提供更自然的解决方案。
与研究机构的合作:
根据伦敦大学学院 2025 计划,再生与精准医学发现中心计划是伦敦大学学院 (UCL) 与包括米尼奥大学在内的葡萄牙大学联盟合作开展的。该中心获得了 1500 万欧元的欧盟「地平线 2020」计画资助,致力于加速临床应用和促进再生医学和精准医学的创新,其总部位于葡萄牙,并在伦敦大学学院设有支持园区。米兰理工大学是与私人牙科公司合作进行临床试验并进一步探索干细胞在牙齿和组织再生中的应用的大学之一。这种协作环境促进了新疗法的发展,并鼓励将干细胞技术融入主流牙科实践。
临床实施:
义大利的几家牙科诊所已开始将干细胞疗法纳入其治疗实践中。例如,博洛尼亚的古列尔莫·马可尼牙科诊所提供再生治疗,利用干细胞作为牙周治疗方法的一部分。这些诊所处于实施创新治疗的前沿,为患者提供管理牙齿和牙龈健康的先进选择。
骨骼和牙龈再生:
干细胞也用于再生因老化、疾病或创伤而出现骨质流失的患者的骨组织,尤其是植牙。利用干细胞进行骨再生有助于提高植入成功率,特别是骨密度不足的患者。义大利的诊所,包括米兰和罗马的诊所,正在采用基于干细胞的骨移植来促进植入物周围骨骼的再生。此外,干细胞疗法显示出牙龈再生的前景。对于严重的牙周病,可以使用干细胞再生牙龈组织,增强牙龈的功能和美观。
阻碍欧洲合约研究组织市场的因素
牙齿再生治疗的高成本是义大利再生牙科市场成长的重大障碍。这些先进的程序包括干细胞疗法、组织工程和牙齿再生技术,由于需要复杂的技术和专业知识,往往很昂贵。结果,许多患者因高昂的费用而却步,限制了市场扩张的潜力。欧洲的牙齿再生治疗费用根据具体治疗程序和进行治疗的国家而有所不同。以下是平均成本的明细:
义大利植牙的平均费用从 1,100 美元到 2,700 美元不等,具体取决于诊所和地点。再生治疗,例如骨移植或干细胞疗法,可能会增加费用,由于涉及先进的材料和技术,有时每次手术的费用高达 5,500-10,800 美元。提供这些服务的诊所,尤其是在米兰和罗马等城市,通常会对再生牙科治疗收取高额费用。
在米兰国际健康中心,一颗牙齿的植入费用可能在 2,200 美元到 2,700 美元之间,而用于牙齿再生的干细胞疗法等再生程序每次治疗的费用可能超过 8,700 美元。同样,位于克利通诺河畔坎佩洛的 Studio Dentistico Cristina Santi 提供再生治疗,费用从 4,800 美元到 9,700 美元不等,具体取决于治疗的复杂程度。
在欧洲,单颗牙植体的价格通常在 1,100 欧元至 2,180 欧元之间,具体取决于国家。在匈牙利、波兰和捷克共和国,费用约为 1,100 欧元。在德国,这个价格大约是 1,700 欧元。在英国,平均费用约为 2,180 欧元。
综合手术,如 All-on-4 植牙,可以替换下颚骨中的所有牙齿,费用在 4,000 欧元至 18,000 欧元之间。总费用取决于植入物的数量和所用材料等因素。
PRP 疗法的费用差异很大,通常每次注射的费用在 500 美元到 2,500 美元之间,具体取决于各种因素。
干细胞治疗费用差异很大,从 5,000 美元到 50,000 美元不等,取决于所施用的干细胞类型、细胞数量、细胞品质、实验室位置和干细胞来源等因素。
这些费用对许多患者来说过于高昂,导致一些患者到国外寻求更实惠的治疗选择。例如,土耳其的植牙起价为 500 欧元,与西欧的价格相比,可节省大量费用。这些治疗方法费用高昂,为其广泛应用设置了若干障碍。许多患者难以负担此类手术的费用,尤其是在没有全面保险的情况下。此外,如果没有明确的投资回报,牙医可能不愿意投资昂贵的再生技术,这进一步限制了许多诊所采用先进技术,并限制了义大利再生牙科市场的成长。因此,虽然牙科再生治疗前景广阔,但这些治疗的高成本仍然是其在欧洲普及和市场扩张的重大障碍。
根据产品类型,欧洲再生牙科市场分为天然生物材料和合成生物材料。 2024 年,天然生物材料在欧洲再生牙科市场占有较大份额。
根据技术,欧洲再生牙科市场分为组织工程、干细胞治疗等。 2024 年,组织工程领域占据欧洲再生牙科市场的最大份额。
在应用方面,欧洲再生牙科市场分为牙周再生、牙髓再生、牙齿重建、骨骼再生等。 2024 年,牙周再生领域占据欧洲再生牙科市场的最大份额。
根据年龄组,市场分为儿童市场和成人市场。 2024 年,成人市场将占据欧洲再生牙科市场的较大份额。
根据最终用户,市场分为医院、牙科诊所和其他。 2024 年,牙科诊所部门占据欧洲再生牙科市场的最大份额。
在撰写欧洲再生牙科市场报告时参考的一些主要一手和二手资料来源包括 Geistlich Pharma AG、Evonik Industries AG、BioHorizons Inc、Nobel Biocare Services AG、UBGEN、B&B Dental Implant Company、Botiss Biomaterials GmbH、Envista Holdings Corporation、ZVie Inc Holdings、Dentsply Sir
The Europe Regenerative Dentistry market was valued at US$ 836.50 million in 2024 and is projected to reach US$ 1,269.60 million by 2031; it is expected to register a CAGR of 6.3% during 2025-2031.The Europe Regenerative Dentistry market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The increasing prevalence of dental disorders in aging population and increasing demand for cosmetic dentistry are the key factors propelling the Europe Regenerative Dentistry Market growth.
Increased Adoption of Tissue Regeneration
Stem cell therapy transforms how dental professionals approach tooth and tissue regeneration, especially for patients with substantial dental damage, tooth loss, or periodontal disease. Below are a few approaches that are likely to bring in new trends in the market:
Tooth Regeneration and Pulp Therapy:
Pulp therapy, particularly vital pulp therapy (VPT), is a critical component of restorative dentistry aimed at preserving the vitality of affected teeth. In Europe, the teaching and application of pulp therapy techniques vary: As per the PubMed, A survey of European dental schools revealed that 92.9% taught the use of ferric sulphate for vital pulpotomy in primary molars, indicating a preference for this material in educational settings. Success rates for VPT in mature permanent teeth have been notable. As per the Springer Nature Limited 2025, retrospective study reported a 99% success rate using iRoot BP Plus for pulpotomy over a 12-24-month follow-up period, highlighting the effectiveness of contemporary materials in pulp therapy. Researchers are exploring stem cell therapies to regenerate damaged or lost tooth pulp, which is crucial for maintaining tooth vitality. In Italy, institutions like the Universita degli Studi di Milano are actively investigating the potential of dental pulp stem cells for regenerating pulp tissue and even re-growing functional teeth. This innovation could replace traditional methods such as root canals or tooth extractions, providing more natural solutions for patients.
Collaboration with Research Institutions:
As per the University College London 2025, Discoveries Centre for Regenerative and Precision Medicine initiative is a collaboration between University College London (UCL) and a consortium of Portuguese universities, including the University of Minho. Supported by a €15 million EU Horizon 2020 grant, the Centre focuses on accelerating clinical applications and fostering innovation in regenerative and precision medicine, with headquarters in Portugal and a supporting campus at UCL. Politecnico di Milano is one of the universities partnering with private dental companies to conduct clinical trials and further explore the applications of stem cells in tooth and tissue regeneration. This collaborative environment fosters the development of new therapies and encourages the integration of stem cell techniques into mainstream dental practice.
Clinical Implementation:
Several dental clinics in Italy have begun incorporating stem cell therapy into their practices. For instance, the Clinica Odontoiatrica Guglielmo Marconi in Bologna offers regenerative treatments that utilize stem cells as part of their approach to periodontal therapy. These clinics are at the forefront of implementing innovative treatments, providing patients with advanced options for managing their tooth and gum health.
Bone and Gum Regeneration:
Stem cells are also used to regenerate bone tissue in patients who have experienced bone loss due to aging, disease, or trauma, particularly dental implants. Utilizing stem cells for bone regeneration helps improve implant success rates, especially for patients with insufficient bone density. Clinics in Italy, including those in Milan and Rome, are incorporating stem cell-based bone grafts to promote the regrowth of bone around implants. Additionally, stem cell therapy shows promise for gum regeneration. In cases of severe periodontal disease, stem cells can be used to regenerate gum tissues, enhancing both the functionality and aesthetic appearance of the gums.
Factor Hampering Europe Contract Research Organization Market
The high cost of dental regeneration treatments is a significant barrier to the growth of the Italy regenerative dentistry market. These advanced procedures, which include stem cell therapies, tissue engineering, and techniques for tooth regeneration, tend to be expensive due to the sophisticated technology and expertise they require. As a result, many patients are discouraged by the steep costs, limiting the market's potential for expansion. The cost of dental regenerative treatments in Europe varies based on the specific procedure and the country where it's performed. Here's a breakdown of average costs:
The average cost of a dental implant in Italy ranges from US$ 1,100 to US$ 2,700, depending on the clinic and location. Regenerative treatments, such as bone grafting or stem cell therapy, can drive up expenses, sometimes reaching US$ 5,500-10,800 per procedure because of the advanced materials and techniques involved. Clinics offering these services, particularly in cities such as Milan and Rome, typically charge premium fees for regenerative dental work.
At the International Health Center in Milan, a dental implant may cost between US$ 2,200 and US$ 2,700, while regenerative procedures like stem cell therapy for tooth regeneration can exceed US$ 8,700 per treatment. Similarly, Studio Dentistico Cristina Santi in Campello sul Clitunno provides regenerative treatments with costs ranging from US$ 4,800 to US$ 9,700, depending on the complexity of the procedure.
The price for a single dental implant in Europe typically ranges between €1,100 and €2,180, depending on the country. In Hungary, Poland, and the Czech Republic, the cost is approximately €1,100. In Germany, it's around €1,700. In the United Kingdom, the average cost is about €2,180.
Comprehensive procedures like All-on-4 implants, which replace all teeth in a jaw, can range from €4,000 to €18,000. The total cost depends on factors such as the number of implants and the materials used.
The cost of PRP therapy varies widely, typically ranging from $500 to $2,500 per injection, depending on various factors.
Stem cell therapy costs can vary significantly, ranging from $5,000 to $50,000, depending on factors such as the type of stem cells administered, the number of cells, the quality of the cells, the location of the laboratory, and the source of the stem cells.
These costs can be prohibitive for many patients, leading some to seek more affordable treatment options abroad. For instance, dental implants in Turkey can start at €500, offering significant savings compared to prices in Western Europe. The high expense of these treatments creates several barriers to their widespread adoption. Many patients struggle to afford such procedures, especially without comprehensive insurance coverage. Additionally, dental practitioners may be reluctant to invest in costly regenerative technologies without a clear return on investment, which further restricts the adoption of advanced techniques in many clinics and limits the growth of the regenerative dentistry market in Italy. Thus, while dental regenerative treatments hold great promise, the high costs associated with these procedures remain a significant obstacle to their accessibility and market expansion in Europe.
Based on product type, the Europe regenerative dentistry market is bifurcated into natural biomaterials and synthetic biomaterials. The natural biomaterials segment held a larger share of the Europe regenerative dentistry market in 2024.
By technology, the Europe regenerative dentistry market is segmented into tissue engineering, stem cell therapy, and others The tissue engineering segment held the largest share of the Europe regenerative dentistry market in 2024.
In terms of application, the Europe regenerative dentistry market is segmented into periodontal regeneration, endodontic regeneration, tooth reconstruction, bone regeneration, and others. The periodontal regeneration segment held the largest share in the Europe regenerative dentistry market in 2024.
By age group, the market is bifurcated into pediatric and adults. The adult segment held a larger share of the Europe regenerative dentistry market in 2024.
Based on end user, the market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Europe regenerative dentistry market in 2024.
A few of the major primary and secondary sources referred to while preparing the report on the Europe Regenerative Dentistry Market are Geistlich Pharma AG, Evonik Industries AG, BioHorizons Inc, Nobel Biocare Services AG, UBGEN, B&B Dental Implant Company, Botiss Biomaterials GmbH, Envista Holdings Corporation, ZimVie Inc, Dentsply Sirona Inc